Anxiety has emerged as a reported side effect in some patients taking semaglutide, affecting approximately 5-8% of users in real-world data
The mechanism of action of semaglutide in patients with obesity is similar to that of liraglutide primarily energy intake reduction but semaglutide has also been shown to improve control of eating and food cravings and reduce preference for fatty, energy-dense foods (6), suggesting that semaglutide may affect food intake via hedonic as well as homeostatic pathways
Zepbound works by mimicking the actions of two hormones, GIP and GLP-1, to suppress appetite and slow digestion
Through a telehealth platform like ours, you can access these sophisticated treatments without the need for in-person waiting rooms or complex pharmacy searches
The majority of evidence supporting the practice of microdosing GLP-1 medications, however, comes from anecdotal evidence and reported benefits from patients and clinicians
Alternative: Meal Delivery Honestly